Please login to the form below
EU
This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.
As May delays, industry warns again of ‘no-deal’ Brexit
She has now flown to Brussels to meet EU27 leaders and EU civil servants to try to rescue the deal. ... Theresa May at an EU summit earlier this year. She has returned to the continent today for further talks - though no substantial changes to the deal
Latest news
-
Industry frustrated by late warning on 'no deal' Brexit disruption
reject Theresa May’s Brexit deal already agreed with the EU. ... 16 weeks until the UK leaves the EU, we need the government to take immediate action to open up alternative supply routes between the UK and Europe and tell companies so
-
Biogen picks up another drug from wide-ranging Ionis alliance
Among others in late-stage development are AB Sciences’ tyrosine kinase inhibitor masitinib, which was turned down by the CHMP in April at its first attempt for EU approval, and Orion
-
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
On Tuesday MPs are expected to roundly dismiss Theresa May’s Brexit deal agreed with the EU, throwing the country’s future direction into confusion, with a very damaging ‘no deal’ ... This would be decided in negotiations to cement a long-term
-
Genomics England reaches 100,000th genome sequencing milestone
positions outside Britain after the country leaves the EU.
-
UK life sciences gets some Brexit relief with £1.3bn sector deal
It’s also a fillip for Prime Minister Theresa May as she tries to win support for her agreement on withdrawing from the EU, which is heading for a parliamentary vote ... D hub as we leave the EU,” commented Mike Thompson, chief executive of the
More from news
Approximately 115 fully matching, plus 1,882 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
US. US and Canada only. # US and EU. Roche’s collaboration with Ionis Pharmaceuticals has a headline of $760m, $1m more than the Tusk deal.
-
Innovation in merger control and the impact on the pharmaceutical sector
How the European Commission looks at the effect of horizontal mergers on innovation is one of the important policy changes championed by European Commissioner Margrethe Vestager, who explained that EU merger
-
Brexit: can pharma 'take back control' of the narrative?
more than 20% of doctors or nurses, and in 92 trusts, more than 10% of doctors or nurses are from the EU. . ... For example the sector has continued to see UK patients gaining slower and lower access to innovative medicines than other EU countries.
-
In conversation with Pfizer’s Erik Nordkamp
Health spending in Belgium and Germany is around 10.4% and 11.1% of GDP respectively, which is higher than the EU average of 9.9% and the UK average of
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
platform. Led by founder and CEO John Maraganore, Alynlam finally crossed the line in August when it gained FDA and EU approval for its first drug, Onpattro.
More from intelligence
Approximately 8 fully matching, plus 153 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications.
-
Trio of senior hires joins Syneos Health
the agency and will serve as the head of integrated communications for the EU, partnering with the firm’s customers who work with Syneos for their marketing communications campaigns.
-
Hanover Brussels appoints Aurélie Marchand as account director
Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”. ... Emma Eatwell, director of EU healthcare, Hanover, said: “With her [Marchand]
-
RJW & Partners appoints new director
She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access.
-
M3 appoints Simon Walker as director of education
M3 EU’s CEO Tim Ringrose said: “I’d like to welcome Simon as our Education Director, a key appointment for M3.
More from appointments
Approximately 2 fully matching, plus 58 partially matching documents found.
Latest from PMHub
-
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report
Living with Psoriasis is a study conducted amongst 615 patients in Europe. The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. It can be purchased as either a 5EU report (sample of 500 patients)
-
A reflection of ESMO
As Ashfield Meetings &Events, our teams of logistics and exhibit experts from our EU and US offices joined the 19, 000 oncology professionals from over 150 countries for this important event
-
More tell, less sell: HCP-centric comms
2015. 10. DRG Digital. Taking the Pulse Europe 2017: Improving the digital physician experience in EU 5 markets.
-
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
In September 2015, it seemed almost impossible that Jeremy Corbyn could lead the Labour Party to victory; since then, the fallout from the vote to leave the EU and the
-
EphMRA round up 2018
EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
More from PMHub
Approximately 3 fully matching, plus 114 partially matching documents found.
Featured jobs
-
Account Manager
-
Negotiable
- Principal Health Economist - North-West
-
Negotiable
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
- Business Development Director – Health Education
-
excellent commission
-
Medical Writer
-
Salary TBC
- Account Manager- Healthcare Advertising
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Associate Director
-
£75, 000-90, 000
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Account Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- Blue Latitude Health joins Fishawack Group of Companies
- Clark Health Communications to bring AI to the forefront with new deal
- Merck exec steps down, two takes his place
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- FDA takes aim at pharma’s biosimilar-delaying tactics
- Circassia seeks shift to AIM after failing LSE criteria
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
